Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01379534
Title A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

endometrial cancer

Therapies

Dovitinib

Age Groups: senior | adult
Covered Countries USA | ITA | ESP

Facility Status City State Zip Country Details
University of South Alabama / Mitchell Cancer Institute Univ South Alabama Mobile Alabama 36688 United States Details
St. Jude Heritage Medical Group St Jude Fullerton California 92835 United States Details
USC/Kenneth Norris Comprehensive Cancer Center USC 2 Los Angeles California 90033 United States Details
Cedars Sinai Medical Center TKI258A2211 (SC) Los Angeles California 90048 United States Details
University of California at Los Angeles UCLA 3 Los Angeles California 90095 United States Details
Rocky Mountain Cancer Centers Dept. of Rocky Mountain Cancer Greenwood Village Colorado United States Details
Florida Hospital Cancer Institute FL Hosp Orlando Florida 32804 United States Details
Indiana University Health Goshen Center for Cancer IU Simon Cancer Indianapolis Indiana 46202 United States Details
University of Iowa Hospitals & Clinics SC Iowa City Iowa 52242 United States Details
Dana Farber Cancer Institute SC Boston Massachusetts 02115 United States Details
Southeast Nebraska Oncology Cancer Center Lincoln Nebraska 68510 United States Details
Hope A Woman's Cancer Center Asheville North Carolina 28806 United States Details
Duke University Medical Center Duke3 Durham North Carolina 27710 United States Details
Community Oncology Research Network Chattanooga Tennessee 37403 United States Details
The West Clinic SC Memphis Tennessee 38120 United States Details
Texas Oncology, P.A. Austin Bedford Texas 76022 United States Details
Texas Oncology, P.A. Tex Onc (3) Bedford Texas 76022 United States Details
Texas Oncology, P.A. SC Fort Worth Texas 76104 United States Details
South Texas Oncology and Hematology, PA South Tex Onc San Antonio Texas 78258 United States Details
Virginia Oncology Associates VOA - Lake Wright *see Various Departments* Virginia United States Details
Cancer Care Northwest SC Spokane Washington 99202 United States Details
Novartis Investigative Site Belo Horizonte MG 30150-270 Brazil Details
Novartis Investigative Site Porto Alegre RS 90610-000 Brazil Details
Novartis Investigative Site Ribeirao Preto SP 14048-900 Brazil Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Pisa PI 56126 Italy Details
Novartis Investigative Site Roma RM 00168 Italy Details
Novartis Investigative Site Candiolo TO 10060 Italy Details
Novartis Investigative Site Seoul Korea 135-710 Korea, Republic of Details
Novartis Investigative Site Seoul 738-736 Korea, Republic of Details
Novartis Investigative Site Grafton, Auckland New Zealand Details
Novartis Investigative Site Cordoba Andalucia 14004 Spain Details
Novartis Investigative Site Málaga Andalucia 29010 Spain Details
Novartis Investigative Site Oviedo Asturias 33006 Spain Details
Novartis Investigative Site Sabadell Barcelona 08208 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Majadahonda Madrid 28222 Spain Details
Novartis Investigative Site Murcia 30008 Spain Details
Novartis Investigative Site Glasgow G12 0YN United Kingdom Details
Novartis Investigative Site Leeds LS9 7TF United Kingdom Details
Novartis Investigative Site London NW1 2BU United Kingdom Details
Novartis Investigative Site Nottingham NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field